Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. - Wikidata - awgldk - TriplyDB

Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.

Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.

http://www.wikidata.org/entity/Q42495427

about

Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation Regulation of the Intestinal Barrier Function by Host Defense Peptides Review article: vitamin D and inflammatory bowel disease--established concepts and future directions Fecal biomarkers of intestinal health and disease in children Antimicrobial proteins in intestine and inflammatory bowel diseases Intestinal barrier in inflammatory bowel disease Lactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasis Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli.The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells.Inflammatory bowel disease: an impaired barrier disease.Antimicrobial peptides and gut microbiota in homeostasis and pathology.Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis.Reduced mucosal antimicrobial activity in Crohn's disease of the colon.Vitamin D-induced up-regulation of human keratinocyte cathelicidin anti-microbial peptide expression involves retinoid X receptor α.Expression of vitamin D receptor and cathelicidin in human corneal epithelium cells during fusarium solani infection.Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide.Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.Human antimicrobial proteins effectors of innate immunity.Role of the intestinal barrier in inflammatory bowel disease.DNA methylation in inflammatory bowel disease and beyond.Crohn's disease--defect in innate defence.Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.Innate antimicrobial immunity in inflammatory bowel diseases.Therapeutic approaches using host defence peptides to tackle herpes virus infections.Antimicrobial peptides and colitis.Intestinal antimicrobial peptides during homeostasis, infection, and disease.Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer.Unique features of human cathelicidin LL-37.MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.Update on clinical and research application of fecal biomarkers for gastrointestinal diseases.Cathelicidin signaling via the Toll-like receptor protects against colitis in mice.The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.Low concentrations of human neutrophil peptide ameliorate experimental murine colitis.Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier.Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNA.The role of natural antimicrobial peptides during infection and chronic inflammation.A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients

P2860

Q24683293-4521D117-C6DF-441E-AB29-820C52C1FD85 Q26776055-959F353E-B176-4BCA-8B27-F901B08900F3 Q27015639-1C35EFA5-6D32-4CFF-B4F4-5D4AAF24B89A Q27021773-F91851F1-AFBE-431A-BBA9-E7FED39D62E8 Q27023239-5AB2F4E9-B76A-4222-9504-207313D118E3 Q27023724-E2C00E30-7935-49B0-B6F9-8DCAEEFE69DC Q28484943-E0C412F1-468C-4B89-B573-BCDA6C1F6D52 Q30945619-DFBFA0C7-077D-45F5-86B3-92CFD29005CA Q33667766-2186FE96-D737-4114-8930-F1963F4D7B3F Q34058861-DF91408D-3E5E-457A-A06E-1181F1055A1F Q34069889-FED512CD-FDE2-45EC-9F9E-8384DA1918B1 Q34312402-32F6F12A-B49E-4766-BF82-1F91D5DB42F5 Q34987870-038FA16A-DEEC-4F9D-A23C-D1CD99D28FD9 Q35113922-F69B4E32-016C-4F72-87D5-91FE7B519582 Q35954105-7BF56A6B-D408-42A3-BA5B-4CAD04B1BDBE Q36064396-E0822F18-2AF4-4392-A309-1E49286CF0E9 Q36243085-94E1D54C-103C-42FD-8A19-024F49BD15FF Q36867412-980FF7CD-65CE-49C8-9681-6DB35BC2D4B7 Q37014671-21CE3C8E-EC0D-4D1D-8DA7-A1F84A6E9F3F Q37053332-EDD4569C-0F21-4C89-B3A0-A0B2B371A99B Q37058869-D044CE8B-9861-4BF0-83C0-87C8C8D1F099 Q37118816-04464BD5-CBB5-49D3-A681-286CBFF2CA8A Q37276947-BAC9B2A3-9D7C-4E65-A162-D5E93B1BB1D4 Q37331557-B6734F48-223D-455E-9A05-0B01B1F423EF Q37774322-82DB9860-44C5-440E-B3FA-2B77B00605B5 Q37786633-2DDEA6CE-59E0-4C7C-9361-497787326509 Q37945181-37EEDEAE-0CF4-46F0-98ED-2042D69485F9 Q38040831-3275E2DC-54B6-4DB0-87CB-B820CCAC7C9F Q38054086-F13FF4C5-E68C-4621-BE24-83BAB02831F6 Q38107933-89113A0F-E19D-453C-9D96-D0CE2402521C Q38598753-417F03EE-568D-47D0-BF4A-32EEA78BC672 Q38722207-57D9D25C-BCBE-4E88-BB64-9E4A5C1A49A6 Q38755379-06D48D6F-B9D3-44AB-A3E8-21B2583F7AC9 Q38792787-35E983C6-B066-4ABA-A117-DF5C8D70D532 Q38822923-B1CCE957-E452-45D7-83AD-F6B2BCC52951 Q39190445-F177E722-C340-4FA0-A29B-6B5454DD277A Q39388017-C97E3BDD-8D04-4C1B-BB0B-20EC0E6F89D2 Q39822897-BEC58CD0-8EAE-4960-ABA7-8C94D81D1A1E Q40063866-F0AC4BA6-1823-4779-95C1-2400D42E2DF2 Q40637403-53A01FDF-CC04-4161-949F-00664C14AB2D

P2860

Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.

http://www.wikidata.org/entity/Q42495427

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Heterogeneous expression of hu ...... n inflammatory bowel diseases.

@en

Heterogeneous expression of hu ...... n inflammatory bowel diseases.

@nl

type

label

Heterogeneous expression of hu ...... n inflammatory bowel diseases.

@en

Heterogeneous expression of hu ...... n inflammatory bowel diseases.

@nl

prefLabel

Heterogeneous expression of hu ...... n inflammatory bowel diseases.

@en

Heterogeneous expression of hu ...... n inflammatory bowel diseases.

@nl

P1433

Q42495427-2FC689D3-4F93-4B5D-9771-E07FC230F247

P1476

Q42495427-F987B63E-9245-4DE0-9B13-FBD2C6B41F33

P2093

Q42495427-17F209E8-6D66-4766-BE4A-F892926AD2B6

Q42495427-727D51E0-9AAB-472D-B523-D888C56F6508

Q42495427-7F5A7E9E-597A-434B-85C7-42BE3931B17A

Q42495427-80A5372B-DC5C-4EEB-8E1D-C4AE65297E59

Q42495427-AB3A66C5-C343-44D2-8670-C17901391766

Q42495427-B3121930-B66A-4E4B-A8E6-ABC2A11F6427

Q42495427-C3E97536-CFAB-4D64-9DEF-B7A451831B64

Q42495427-EF6D41CB-7C4C-4E93-9FD0-DA90D60A12CD

Q42495427-FE1D1BF7-8D7D-4777-BAB1-A7D0EFEFD94D

P304

Q42495427-471E267B-7A22-4565-B560-1C123DDEA005

P31

Q42495427-ED4228E0-0C66-47D4-A47C-7E7158DAEB89

P356

Q42495427-F7710923-9282-47BE-9068-D70654FB5037

P433

Q42495427-EB70269B-0605-43DE-913B-B6524B1B3651

P478

Q42495427-099B4207-8D44-42A3-982B-D5898D5FC9BE

P577

Q42495427-07C791EC-897E-4545-87C6-60EA64FEF0CE

P698

Q42495427-156F3A75-CF1A-4E2F-BC84-FAB146E04B56

P921

Q42495427-4D234F29-D940-4DE1-B676-51D13CC5608F

Q42495427-86ADE1C4-4FBC-4F49-9789-60350829CE50

P356

00042737-200606000-00007

P1433

European Journal of Gastroenterology and Hepatology

P1476

Heterogeneous expression of hu ...... n inflammatory bowel diseases.

@en

P2093

Daniel Rieger

http://www.w3.org/2001/XMLSchema#string

Eduard F Stange

http://www.w3.org/2001/XMLSchema#string

Frank Weiler

http://www.w3.org/2001/XMLSchema#string

Jan Wehkamp

http://www.w3.org/2001/XMLSchema#string

Jürgen Schauber

http://www.w3.org/2001/XMLSchema#string

Klaus Fellermann

http://www.w3.org/2001/XMLSchema#string

Matthias Eck

http://www.w3.org/2001/XMLSchema#string

Richard L Gallo

http://www.w3.org/2001/XMLSchema#string

Wolfgang Scheppach

http://www.w3.org/2001/XMLSchema#string

P304

615-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00042737-200606000-00007

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16702850

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases